Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals. Hasson H, Merli M, Messina E, Bhoori S, Salpietro S, Morsica G, Regalia E, Bagaglio S, Lazzarin A, Uberti-Foppa C, Mazzaferro V. J Hepato…

Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH). Marcellin F, Protopopescu C, Esterle L, Wittkop L, Piroth L, Aumaitre H, Bouchaud O, Goujard C, Vittecoq D, Dabis F, Salm…

Genf – Rund 325 Millionen Menschen sind nach Schätzungen der Weltgesundheitsorganisation (WHO) mit chronischer Hepatitis B oder Hepatitis C infiziert, aber nur ein Bruchteil von ihnen weiß das. Darauf hat die WHO aufmerksam gemacht…

Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir In Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials. Jacobson IM, Lawitz E, Gane EJ, Willems BE, Ruane PJ, Nahass RG, Borgia SM, Shafran SD, Workowski KA, Pearlman B…

https://www.easl.eu/

A review of recent reimbursement data showed considerable variability in access to direct-acting antiviral therapy based on amount of liver scarring and substance use. (European Association for the Study of the Liver, Press Release, 20.04.2017) htt…